TILS

TIZIANA LIFE SCIENCES PLC ORD 3P

TitleTime
Second Price Monitoring ExtnFri 22/05/20 | 09:05
Price Monitoring ExtensionFri 22/05/20 | 09:00
Intention to Demerge StemPrintERFri 22/05/20 | 07:00
Holding(s) in CompanyThu 21/05/20 | 16:05
Exercise of Warrants and Issue of EquityMon 18/05/20 | 14:39
Second Price Monitoring ExtnMon 18/05/20 | 11:05
Price Monitoring ExtensionMon 18/05/20 | 11:00
ASCO Conference - MilciclibThu 14/05/20 | 15:00
Second Price Monitoring ExtnThu 14/05/20 | 14:06
Price Monitoring ExtensionThu 14/05/20 | 14:00
Second Price Monitoring ExtnThu 14/05/20 | 11:05
Price Monitoring ExtensionThu 14/05/20 | 11:00
Second Price Monitoring ExtnThu 14/05/20 | 09:05
Price Monitoring ExtensionThu 14/05/20 | 09:00
ASCO Conference - StemPrintERThu 14/05/20 | 07:00
Second Price Monitoring ExtnWed 13/05/20 | 11:06
Price Monitoring ExtensionWed 13/05/20 | 11:00
Holding(s) in CompanyMon 11/05/20 | 10:47
ASCO ConferenceMon 11/05/20 | 07:00
Second Price Monitoring ExtnThu 07/05/20 | 11:06
Price Monitoring ExtensionThu 07/05/20 | 11:00
Result of GMWed 06/05/20 | 12:13
Holding(s) in CompanyWed 06/05/20 | 07:00
Total Voting RightsFri 01/05/20 | 07:00
Price Monitoring ExtensionTue 28/04/20 | 14:00
Second Price Monitoring ExtnTue 28/04/20 | 11:05
Price Monitoring ExtensionTue 28/04/20 | 11:00
Price Monitoring ExtensionMon 27/04/20 | 14:01
Patent Application FilingMon 27/04/20 | 13:30
Acquisition of TechnologyFri 24/04/20 | 18:29
Issue of Equity and Update on AIM CancellationFri 24/04/20 | 07:00
Second Price Monitoring ExtnTue 21/04/20 | 16:40
Price Monitoring ExtensionTue 21/04/20 | 16:36
Notice of GMTue 21/04/20 | 07:00
Second Price Monitoring ExtnThu 16/04/20 | 09:05
Price Monitoring ExtensionThu 16/04/20 | 09:00
Further Re: Block Listing ApplicationWed 15/04/20 | 16:31
Second Price Monitoring ExtnWed 15/04/20 | 11:05
Price Monitoring ExtensionWed 15/04/20 | 11:00
Block Listing ApplicationWed 15/04/20 | 07:00
Issue of EquityWed 15/04/20 | 07:00
Second Price Monitoring ExtnTue 14/04/20 | 16:41
Price Monitoring ExtensionTue 14/04/20 | 16:37
Second Price Monitoring ExtnTue 14/04/20 | 11:06
Price Monitoring ExtensionTue 14/04/20 | 11:01
Tiziana Develops Treatment For COVID-19 PatientsThu 09/04/20 | 07:00
Closing of OfferMon 16/03/20 | 17:21
Tiziana U.S. Follow-On Offering of $10 millionThu 12/03/20 | 07:00
TZLS-501 / COVID-19Wed 11/03/20 | 07:00
Result of GMThu 20/02/20 | 10:30
Proposed U.S. Public Offering of ADSsMon 17/02/20 | 07:00
Director/PDMR ShareholdingTue 04/02/20 | 12:00
Notice of GMMon 03/02/20 | 07:00
Filing of SEC Form F-3Thu 23/01/20 | 07:00
Director AppointmentTue 21/01/20 | 14:45
Director/PDMR ShareholdingTue 14/01/20 | 11:00
Proposed Cancellation from AIMMon 13/01/20 | 07:00
Further re: Foralumab Phase 1 TrialThu 09/01/20 | 07:00
Director/PDMR ShareholdingThu 02/01/20 | 15:00
Foralumab Phase 1 TrialWed 04/12/19 | 07:00
Issue of Equity and Directorate ChangeWed 20/11/19 | 07:00
Issue of CLNFri 01/11/19 | 07:00
Change to ADS ratioWed 30/10/19 | 10:31
Half-year ReportMon 30/09/19 | 07:00
Further re: Update on IND ApplicationMon 16/09/19 | 07:00
Phase 1 Clinical DataTue 10/09/19 | 07:00
Phase 2a Clinical DataWed 04/09/19 | 07:00
Second Price Monitoring ExtnWed 21/08/19 | 16:40
Price Monitoring ExtensionWed 21/08/19 | 16:35
Proposed U.S. Public OfferingTue 06/08/19 | 07:00
Phase 2a Clinical DataMon 22/07/19 | 07:00
Second Price Monitoring ExtnFri 28/06/19 | 16:40
Price Monitoring ExtensionFri 28/06/19 | 16:35
Change of AdviserFri 28/06/19 | 10:54
Director/PDMR ShareholdingTue 25/06/19 | 07:00
Director/PDMR ShareholdingTue 11/06/19 | 07:00
Director/PDMR ShareholdingFri 07/06/19 | 09:44
PDMR DealingsMon 03/06/19 | 07:00
Result of AGMFri 31/05/19 | 11:05
9th Annual LD Micro InvitationalTue 28/05/19 | 07:00
Notice of AGMTue 07/05/19 | 07:00
Director/PDMR ShareholdingThu 02/05/19 | 07:00
Update on IND ApplicationWed 01/05/19 | 07:00
Director/PDMR ShareholdingThu 25/04/19 | 17:00
Second Price Monitoring ExtnThu 25/04/19 | 11:06
Price Monitoring ExtensionThu 25/04/19 | 11:00
Reissue: Interim Clinical DataWed 24/04/19 | 12:55
Interim Clinical DataWed 24/04/19 | 07:00
Holding(s) in CompanyMon 15/04/19 | 17:45
Holding(s) in CompanyMon 15/04/19 | 17:45
Holding(s) in CompanyMon 15/04/19 | 17:45
Final ResultsThu 04/04/19 | 07:00
IND Application Submitted for NASH Oral TreatmentWed 20/03/19 | 07:00
Directorate ChangeThu 07/02/19 | 07:00
Exercise of Warrants & Issue of EquityTue 11/12/18 | 07:00
Milciclib HCC Phase IIa Trial Enrollment CompletedMon 03/12/18 | 07:00
Foralumab: Phase 1 Trial with Nasal AdministrationWed 28/11/18 | 07:00
Holding(s) in CompanyTue 27/11/18 | 07:00
Closing of Offering and Total Voting RightsFri 23/11/18 | 17:00
Discounted exercise prices of outstanding warrantsTue 20/11/18 | 07:30
Offer Pricing, Nasdaq Listing & Loan ConversionTue 20/11/18 | 07:00
Issue of EquityFri 26/10/18 | 17:30
Amended Registration Statement filed with the SECThu 18/10/18 | 07:15
Tiziana announces Offering & Application to NasdaqTue 25/09/18 | 07:00
Interim Results for Six Months Ended 30 June 2018Mon 24/09/18 | 07:03
U.S. FDA Approval IND Nasal Foralumab Phase 1Mon 24/09/18 | 07:00
PDMR DealingThu 13/09/18 | 13:05
PDMR dealingsWed 12/09/18 | 07:00
PDMR DealingTue 11/09/18 | 07:00
PDMR DealingFri 24/08/18 | 07:00
PDMR dealingsTue 21/08/18 | 07:00
PDMR DealingMon 20/08/18 | 07:00
PDMR DealingFri 17/08/18 | 07:00
Filing of Investigational New Drug applicationThu 16/08/18 | 09:00
US Registration Statement for Proposed OfferingFri 27/07/18 | 07:00
Result of AGMMon 25/06/18 | 10:49
Appointment of BrokerThu 07/06/18 | 07:01
Final ResultsThu 07/06/18 | 07:00
Notice of AGMFri 01/06/18 | 07:00
Second Price Monitoring ExtnWed 23/05/18 | 16:40
Price Monitoring ExtensionWed 23/05/18 | 16:35
Milciclib Phase 2a Trial - Tolerability UpdateWed 16/05/18 | 07:00
Grant of Options - Director DealingTue 01/05/18 | 15:00
Issue of EquityFri 27/04/18 | 07:00
SubscriptionThu 19/04/18 | 07:00
License AgreementMon 16/04/18 | 07:25
Presentation at ASCO 3 June 2018Mon 09/04/18 | 08:25
Appointment of BrokerThu 05/04/18 | 07:00
Appointment of DirectorWed 04/04/18 | 07:00
Placing to raise £600,000 and issue of equityMon 05/03/18 | 07:00
Statement re brokerFri 02/03/18 | 12:09
PlacingMon 22/01/18 | 07:00
PlacingTue 16/01/18 | 07:00
Placing and Issue of EquityFri 15/12/17 | 07:00
Milciclib Phase 2a Trial UpdateFri 08/12/17 | 07:00
PlacingMon 27/11/17 | 07:00
Phase II Clinical Trial UpdateThu 23/11/17 | 07:00
SubscriptionMon 20/11/17 | 07:00
Interim Results for Six Months Ended 30 June 2017Fri 29/09/17 | 07:00
A Proprietary Oral Formulation of ForalumabWed 06/09/17 | 07:00
Grant of options - Director's dealingThu 31/08/17 | 11:07
Conversion of outstanding loan notesWed 16/08/17 | 07:00
Publication of Research Article on ForalumabFri 28/07/17 | 07:00
Initiation of a Phase IIa Clinical TrialWed 19/07/17 | 07:00
Proposed changes to CLNs and Warrant TermsWed 12/07/17 | 07:00
Result of AGMThu 29/06/17 | 11:21